NM_002945.5:c.374C>G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_002945.5(RPA1):​c.374C>G​(p.Pro125Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,461,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

RPA1
NM_002945.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.771
Variant links:
Genes affected
RPA1 (HGNC:10289): (replication protein A1) This gene encodes the largest subunit of the heterotrimeric Replication Protein A (RPA) complex, which binds to single-stranded DNA (ssDNA), forming a nucleoprotein complex that plays an important role in DNA metabolism, being involved in DNA replication, repair, recombination, telomere maintenance, and co-ordinating the cellular response to DNA damage through activation of the ataxia telangiectasia and Rad3-related protein (ATR) kinase. The nucleoprotein complex protects the single-stranded DNA from nucleases, prevents formation of secondary structures that would interfere with repair, and co-ordinates the recruitment and departure of different genome maintenance factors. This subunit contains four oligonucleotide/oligosaccharide-binding (OB) domains, though the majority of ssDNA binding occurs in two of these domains. The heterotrimeric complex has two different modes of ssDNA binding, a low-affinity and high-affinity mode, determined by which ssDNA binding domains are utilized. The different binding modes differ in the length of DNA bound and in the proteins with which it interacts, thereby playing a role in regulating different genomic maintenance pathways. [provided by RefSeq, Sep 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.085246235).
BS2
High AC in GnomAdExome4 at 16 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPA1NM_002945.5 linkc.374C>G p.Pro125Arg missense_variant Exon 6 of 17 ENST00000254719.10 NP_002936.1 P27694
RPA1NM_001355120.2 linkc.335C>G p.Pro112Arg missense_variant Exon 6 of 17 NP_001342049.1
RPA1NM_001355121.2 linkc.374C>G p.Pro125Arg missense_variant Exon 6 of 16 NP_001342050.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPA1ENST00000254719.10 linkc.374C>G p.Pro125Arg missense_variant Exon 6 of 17 1 NM_002945.5 ENSP00000254719.4 P27694
RPA1ENST00000570451.5 linkc.335C>G p.Pro112Arg missense_variant Exon 6 of 7 3 ENSP00000459788.1 I3L2M5
RPA1ENST00000571058.5 linkc.335C>G p.Pro112Arg missense_variant Exon 6 of 6 4 ENSP00000461733.1 I3L524
RPA1ENST00000573924.1 linkn.98C>G non_coding_transcript_exon_variant Exon 2 of 6 4

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.0000109
AC:
16
AN:
1461630
Hom.:
0
Cov.:
31
AF XY:
0.00000688
AC XY:
5
AN XY:
727108
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000144
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 27, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.374C>G (p.P125R) alteration is located in exon 6 (coding exon 6) of the RPA1 gene. This alteration results from a C to G substitution at nucleotide position 374, causing the proline (P) at amino acid position 125 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
16
DANN
Benign
0.44
DEOGEN2
Benign
0.029
T;T;T
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.44
T;T;T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.085
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
.;.;L
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.1
.;.;N
REVEL
Benign
0.074
Sift
Benign
0.52
.;.;T
Sift4G
Benign
0.15
T;T;T
Polyphen
0.0010
.;.;B
Vest4
0.23
MutPred
0.23
.;.;Gain of catalytic residue at P125 (P = 0.095);
MVP
0.60
MPC
0.26
ClinPred
0.15
T
GERP RS
3.6
Varity_R
0.032
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-1775740; API